65,437 trials
Osteoarthritis, Knee · Knee Degenerative Disease · Knee Osteoarthritis
Primary: Feasibility and Safety of the Implementation of MSV in the Treatment of Osteoarthritis of the Knee. — 46.9; 25.1; 24.8; 15.4 units on a scale
Cataract
Primary: Mean Monocular Distance-corrected Near Visual Acuity (VA) at 40 cm — 0.253; 0.179; 0.582 LogMAR VA
PTSD · Stress Disorders, Post-Traumatic
Primary: Neuropsychological Testing of Memory — 77; 82 percentage of WMS retention
Autism Spectrum Disorders
Primary: Total Brain Volume — 1634.1; 1409.8; 1236.7; 1401.9 cubic centimeters
Metastatic or Unresectable Solid Tumor Malignancy
Primary: Dose Determination — 70; 1250 mg/m^2
Kidney Failure, Chronic · End-Stage Renal Disease
Primary: Primary Efficacy: Compare the Ability to Deliver the Clinically Prescribed Amount of Therapy in the Nocturnal Hemodialysis and Short Daily Hemodialysis Phases. — 90.9…
Cardiopulmonary Bypass Induced Lipid Peroxidation
Primary: Plasma Isofuran Concentrations — 61.5; 67.7; 72.1; 82.7 pg/mL — p=0.05
Hot Flushes
Primary: Daily Diary Ratings of Frequency of Hot Flashes — 3.65; 4.71 number of hot flashes — p=0.05
Asthma
Primary: Change From Baseline in Morning (Ante Meridiem) Peak Expiratory Flow Rate (AM PEFR) at Day 112 - Stage 1 — 286.4; 297.6; 343.5; 291.5 liter per minute (L/min)
Autosomal Dominant Polycystic Kidney Disease
Primary: Primary Efficacy Analysis of Total Kidney Volume (mITT Set, Multiple Imputation) — 230.1; 300.8 mL
Tinnitus
Primary: Tinnitus Distress Rating — 5.71; 5.82; 5.36; 5.46 units on a scale
Metastatic Colorectal Cancer
Primary: To Determine the Maximum Tolerated Dose (MTD) of the Combination of OSI-906 and Everolimus for the Treatment of Patients With Refractory Metastatic Colorectal Cancer…
Allergic Rhinitis
Primary: Scores on a Scale (Average of Daily Rhinoconjunctivitis Symptom Score (RSS) Recorded During the Ragweed Season — 6.2; 6.5 Scores on a scale — p=<0.05
Parkinson Disease
Primary: Cmax - Maximum Plasma Concentration — 407.4; 391.1; 439.6; 382.0 ng/mL
Non-Small Cell Lung Cancer
Primary: 2 Year Rate of Overall Local-Regional Tumor Control Using FGD-PET-CT During Radiation Therapy(RT) — 68 percentage of patients